Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 4/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28094491 | 0.97 | ALDH1A1 (0.46) | ALDH1A1TSHRTHRBTDP1HSD17B10 | |
| SCHEMBL27610743 | 0.81 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRBTDP1HSD17B10 | |
| SCHEMBL28862258 | 0.79 | ALDH1A1 (0.48) | ALDH1A1TSHRTHRBTDP1HSD17B10 | |
| SCHEMBL999439 | 0.79 | ALDH1A1 (0.48) | ALDH1A1TSHRTHRBTDP1HSD17B10 | |
| SCHEMBL28285490 | 0.77 | ALDH1A1 (0.46) | ALDH1A1TSHRTHRBTDP1HSD17B10 | |
| SCHEMBL28697109 | 0.77 | ALDH1A1 (0.46) | ALDH1A1TSHRTHRBTDP1HSD17B10 | |
| SCHEMBL27484447 | 0.77 | ALDH1A1 (0.46) | ALDH1A1TSHRTHRBTDP1HSD17B10 | |
| SCHEMBL9589440 | 0.75 | ALDH1A1 (0.44) | ALDH1A1TSHRTHRBTDP1 | |
| SCHEMBL7049607 | 0.75 | ALDH1A1 (0.44) | ALDH1A1TSHRTHRBTDP1 | |
| SCHEMBL154125 | 0.75 | ALDH1A1 (0.44) | ALDH1A1TSHRTHRBTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230130822-A1 | LOW TOXICITY NMP SUBSTITUTES AND USES THEREOF | ADVANCION CORPORATION | 2023-04-27 | — | — | US | disclosed |
| EP-4103550-A2 | LOW TOXICITY NMP SUBSTITUTES AND THEIR PREPARATION | ANGUS Chemical Company (US) | 2022-12-21 | — | — | EP | disclosed |
| CN-115335360-A | Low toxicity NMP substitutes and their preparation | 安格斯化学公司 | 2022-11-11 | — | — | CN | disclosed |
| WO-2021163348-A2 | LOW TOXICITY NMP SUBSTITUTES AND USES THEREOF | ANGUS CHEMICAL COMPANY (US) | 2021-08-19 | — | — | WO | disclosed |
| US-8859183-B2 | N-acyl-β-lactam derivative, macromolecular compound, and photoresist composition | KURARAY CO., LTD. (JP) | 2014-10-14 | — | — | US | disclosed |
| US-8771859-B2 | Separator for battery and nonaqueous electrolyte battery using same | HITACHI MAXELL, LTD. (IL) | 2014-07-08 | — | — | US | disclosed |
| US-8753794-B2 | N-acyl-β-lactam derivative, macromolecular compound, and photoresist composition | KURARAY CO., LTD. (JP) | 2014-06-17 | — | — | US | disclosed |
| CN-103857752-A | Azo pigment, method for producing azo pigment, dispersion containing azo pigment, tinting composition and inkjet recording ink | FUJI PHOTO FILM CO LTD | 2014-06-11 | — | — | CN | disclosed |
| CN-103649233-A | Process for producing azo pigment | FUJIFILM COPORATION | 2014-03-19 | — | — | CN | disclosed |
| US-20140038106-A1 | N-ACYL-B-LACTAM DERIVATIVE, MACROMOLECULAR COMPOUND, AND PHOTORESIST COMPOSITION | KURARAY CO., LTD. (JP) | 2014-02-06 | — | — | US | disclosed |
| US-20110009643-A1 | METHOD FOR PRODUCING ACRYLATE DERIVATIVE, ACRYLATE DERIVATIVE, AND INTERMEDIATE THEREOF | KURARAY CO., LTD. (JP) | 2011-01-13 | — | — | US | disclosed |
| US-7867690-B2 | Tertiary alcohol derivative, polymer compound and photoresist composition | KURARAY CO., LTD. (JP) | 2011-01-11 | — | — | US | disclosed |
| US-20090035700-A1 | TERTIARY ALCOHOL DERIVATIVE, POLYMER COMPOUND AND PHOTORESIST COMPOSITION | KURARAY CO., LTD. (JP) | 2009-02-05 | — | — | US | disclosed |
| US-20090029290-A1 | TERTIARY ALCOHOL DERIVATIVE, POLYMER COMPOUND AND PHOTORESIST COMPOSITION | KURARAY CO., LTD. (JP) | 2009-01-29 | — | — | US | disclosed |
| EP-1992650-A1 | TERTIARY ALCOHOL DERIVATIVE, POLYMER COMPOUND AND PHOTORESIST COMPOSITION | Kuraray Co., Ltd. (JP) | 2008-11-19 | — | — | EP | disclosed |
| EP-1992651-A1 | TERTIARY ALCOHOL DERIVATIVE, POLYMER COMPOUND AND PHOTORESIST COMPOSITION | Kuraray Co., Ltd. (JP) | 2008-11-19 | — | — | EP | disclosed |
| CN-1240154-C | Electrochemical element electrode and battery using such electrode | HITACHI MAXELL (JP) | 2006-02-01 | — | — | CN | disclosed |
| CN-1481045-A | Electrochemical element electrode and battery using such electrode | 日立麦克赛尔株式会社 | 2004-03-10 | — | — | CN | disclosed |
| US-20010018881-A1 | Cement admixture and cement composition | SHOWA DENKO K.K. (JP) | 2001-09-06 | — | — | US | disclosed |
| EP-1112982-A1 | Cement admixture and cement composition | Showa Denko Kabushiki Kaisha (JP) | 2001-07-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090029290-A1 | TERTIARY ALCOHOL DERIVATIVE, POLYMER COMPOUND AND PHOTORESIST COMPOSITION | ADH1A, ADH1C, ADH5 | ALDH1A1 247/4885TSHR 2294/4885THRB 3774/4885 |
| US-20230130822-A1 | LOW TOXICITY NMP SUBSTITUTES AND USES THEREOF | NME4, NMBR, NMUR1 | ALDH1A1 1133/4885TSHR 3306/4885THRB 2392/4885 |
| US-20110009643-A1 | METHOD FOR PRODUCING ACRYLATE DERIVATIVE, ACRYLATE DERIVATIVE, AND INTERMEDIATE THEREOF | ACR, ADH1A, ALAD | ALDH1A1 13/4885TSHR 3908/4885THRB 4069/4885 |
| US-20090035700-A1 | TERTIARY ALCOHOL DERIVATIVE, POLYMER COMPOUND AND PHOTORESIST COMPOSITION | ADH1A, ADH1C, CCNT1 | ALDH1A1 337/4885TSHR 1932/4885THRB 4495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.